Abstract:The tumor microbiome, a complex community of microbes found in tumors, has been found to be linked to cancer development, progression, and treatment outcome. However, it remains a bottleneck in distangling the relationship between the tumor microbiome and host gene expressions in tumor microenvironment, as well as their concert effects on patient survival. In this study, we aimed to decode this complex relationship by developing ASD-cancer (autoencoder-based subtypes detector for cancer), a semi-supervised deep learning framework that could extract survival-related features from tumor microbiome and transcriptome data, and identify patients' survival subtypes. By using tissue samples from The Cancer Genome Atlas database, we identified two statistically distinct survival subtypes across all 20 types of cancer Our framework provided improved risk stratification (e.g., for liver hepatocellular carcinoma, [LIHC], log-rank test, P = 8.12E-6) compared to PCA (e.g., for LIHC, log-rank test, P = 0.87), predicted survival subtypes accurately, and identified biomarkers for survival subtypes. Additionally, we identified potential interactions between microbes and host genes that may play roles in survival. For instance, in LIHC, Arcobacter, Methylocella, and Isoptericola may regulate host survival through interactions with host genes enriched in the HIF-1 signaling pathway, indicating these species as potential therapy targets. Further experiments on validation data sets have also supported these patterns. Collectively, ASD-cancer has enabled accurate survival subtyping and biomarker discovery, which could facilitate personalized treatment for broad-spectrum types of cancers.IMPORTANCEUnraveling the intricate relationship between the tumor microbiome, host gene expressions, and their collective impact on cancer outcomes is paramount for advancing personalized treatment strategies. Our study introduces ASD-cancer, a cutting-edge autoencoder-based subtype detector. ASD-cancer decodes the complexities within the tumor microenvironment, successfully identifying distinct survival subtypes across 20 cancer types. Its superior risk stratification, demonstrated by significant improvements over traditional methods like principal component analysis, holds promise for refining patient prognosis. Accurate survival subtype predictions, biomarker discovery, and insights into microbe-host gene interactions elevate ASD-cancer as a powerful tool for advancing precision medicine. These findings not only contribute to a deeper understanding of the tumor microenvironment but also open avenues for personalized interventions across diverse cancer types, underscoring the transformative potential of ASD-cancer in shaping the future of cancer care.

Deep Subspace Mutual Learning for Cancer Subtypes Prediction

Integrating Multi-Omic Data with Deep Subspace Fusion Clustering for Cancer Subtype Prediction

Deep Subspace Similarity Fusion for the Prediction of Cancer Subtypes

Deep multi-view contrastive learning for cancer subtype identification

Subtype-DCC: decoupled contrastive clustering method for cancer subtype identification based on multi-omics data

A Contrastive-Learning-Based Deep Neural Network for Cancer Subtyping by Integrating Multi-Omics Data

DeepTpNet: A Deep Learning Approach to Identify Cancer Subtypes Based on Multi-omics Data.

Functional Analysis of Molecular Subtypes with Deep Similarity Learning Model Based on Multi-omics Data

Multi -View Spectral Clustering with Latent Representation Learning for Applications on Multi-Omics Cancer Subtyping

Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning

Comparative Evaluation of Machine Learning Models for Subtyping Triple-Negative Breast Cancer: A Deep Learning-Based Multi-Omics Data Integration Approach

Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach

Multi-layer matrix factorization for cancer subtyping using full and partial multi-omics dataset

DeepCC: a Novel Deep Learning-Based Framework for Cancer Molecular Subtype Classification

A Hybrid Deep Learning Model for Predicting Molecular Subtypes of Human Breast Cancer Using Multimodal Data

Subtype-Former: a deep learning approach for cancer subtype discovery with multi-omics data

Deep Learning Enabled Integration of Tumor Microenvironment Microbial Profiles and Host Gene Expressions for Interpretable Survival Subtyping in Diverse Types of Cancers.

Integration of Multimodal Data from Disparate Sources for Identifying Disease Subtypes

MDICC: novel method for multi-omics data integration and cancer subtype identification

MOCSS: Multi-omics Data Clustering and Cancer Subtyping Via Shared and Specific Representation Learning

Multi-view contrastive clustering for cancer subtyping using fully and weakly paired multi-omics data